Document is current

Any future updates will be listed below

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial

Crossref DOI link: https://doi.org/10.1186/s12885-015-1871-z

Published Online: 2015-11-02

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark